MeiraGTx Announces Oral Presentation at ObesityWeek 2026
Presentation highlights the Company’s AAV-BDNF program for the treatment of severe early-onset obesity Presentation highlights the Company’s AAV-BDNF program for the treatment of severe early-onset obesity